Higher levels of platelets were observed in patients with the CALR mutation, although this finding did not reach statistical significance ( p = 0.08).
← all excerpts
Clinical and molecular profile of a Brazilian cohort of patients with classical BCR-ABL1-negative myeloproliferative neoplasms.
1
0.0800
0.0800